CBIO
Crescent Biopharma
CBIO
CBIO
58 hedge funds and large institutions have $72.5M invested in Crescent Biopharma in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
34% less capital invested
Capital invested by funds: $110M → $72.5M (-$37.8M)
69% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 29
Holders
58
Holding in Top 10
–
Calls
$1.06M
Puts
$931K
Top Buyers
| 1 | +$1.48M | |
| 2 | +$711K | |
| 3 | +$373K | |
| 4 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$316K |
| 5 |
Renaissance Technologies
New York
|
+$304K |
Top Sellers
| 1 | -$4.5M | |
| 2 | -$3.19M | |
| 3 | -$1.49M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.18M |
| 5 |
SCM
Sio Capital Management
New York
|
-$1.07M |